Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 149

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 149
---
 minority shareholders, which may limit our ability to integrate operations with our other subsidiaries. If we make an investment as a minority investor, we are unlikely to exert much, if any, control over the business and we may be limited in our ability to realize value from those investments. We currently own wholly -ownedsubsidiaries, and plan to be the majority owner of future subsidiaries. In the event that we acquire a majority ownership interest or make an investment in another company, or if any of our subsidiaries require additional capital and such additional capital is obtained from third party investors rather than from us, we may be (or may become) a minority shareholder and unable to control the business and operations of those companies. If the companies in which we are a minority shareholder conduct their business in a manner detrimental to our interests, business, or reputation, our returns may be adversely affected. Companies in which we are a minority shareholder may not consult us on business decisions and could take actions without our consent, which could have an adverse impact on our returns. If we acquire less than all of the ownership interests in a subsidiary or if we reduce our interest in a wholly -ownedsubsidiary, our resulting majority ownership will create additional risks because we must be sure that any contracts between such subsidiaries and our company or any of our other subsidiaries are conducted on an “arms -length” basis. As a result, we will be unable to manage majority -ownedsubsidiaries in the same fashion as our wholly -ownedsubsidiaries (where contracts with affiliates need not be on an arms -lengthbasis). These constraints may require management to incur time and resources to determine “arms -length” provisions of contracts 77 with majority -ownedsubsidiaries. Minority shareholders of majority -ownedsubsidiaries may, after the fact, claim breach of fiduciary duties with respect to contracts that they assert are not “arms -length” or not fair to the minority shareholders. These types of claims may result in judgments or settlements that require us or our subsidiaries to pay damages to the minority shareholders. A single or limited number of portfolio companies may comprise a large proportion of our value. A large proportion of our value may, at any time, reside in one or two of our subsidiaries, including intellectual property rights and the value ascribed to the product candidate or program that it is developing. Our consolidated financial condition and prospects may be materially diminished if the clinical development or potential commercialization prospects of a subsidiary’s product candidate or program or one or more of the intellectual property rights held by a